Mayo Clinic Consensus Statement for the Use of Bisphosphonates in Multiple Myeloma-Reference-Cited by-同舟云学术

Mayo Clinic Consensus Statement for the Use of Bisphosphonates in Multiple Myeloma

Published:2006-08 Issue:8 Volume:81 Page:1047-1053
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Lacy Martha Q.,Dispenzieri Angela,Gertz Morie A.,Greipp Philip R.,Gollbach Kimberly L.,Hayman Suzanne R.,Kumar Shaji,Lust John A.,Rajkumar S. Vincent,Russell Stephen J.,Witzig Thomas E.,Zeldenrust Steven R.,Dingli David,Bergsagel P. Lief,Fonseca Rafael,Reeder Craig B.,Stewart A. Keith,Roy Vivek,Dalton Robert J.,Carr Alan B.,Kademani Deepak,Keller Eugene E.,Viozzi Christopher F.,Kyle Robert A.

Publisher

Elsevier BV

Subject

General Medicine

Reference60 articles.

1. Multiple myeloma: clinical features and indications for therapy;Dispenzieri;Best Pract Res Clin Haematol,2005

2. Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma: final time-to-event results from the SUMMIT trial;Richardson;Cancer,2006

3. Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group;Rajkumar;J Clin Oncol,2006

4. Thalidomide with dexamethasone for resistant multiple myeloma [abstract];Weber;Blood,2000

5. Durable response to thalidomide in relapsed/refractory multiple myeloma (MM);Raza;Blood,2000

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of bone-modifying agents in multiple myeloma;Blood Reviews;2023-01

2. Prognosis by cancer type and incidence of zoledronic acid–related osteonecrosis of the jaw: a single-center retrospective study;Supportive Care in Cancer;2022-02-03

3. Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium;Clinical Lymphoma Myeloma and Leukemia;2022-01

4. PREVENTION AND SCREENING OF OSTEONECROSIS OF JAW (ONJ) IN MYELOMA PATIENTS : A MONOISTITUTIONAL FIFTEEN-YEAR EXPERIENCE;Qeios;2021-04-25

5. Evaluation of the osteoporosis patient;Marcus and Feldman's Osteoporosis;2021